It's one of the things that I like about this drug, and the Acne formulation as well for that matter which I maintain is the real revenue giant if approved, is they don't cure the problem. They only treat the symptoms. So if this formulation works as intended for x% of the population then logic dictates most should return and the patient base will consistently grow as new prospective patients are born and are afflicted with the condition - Long term view.
Acne is the one I am most exited for - the target population is massive and it hit's the cosmetic / vanity sweet spot that redefines the drug into a must have for basically anyone going through puberty and it's a self generating patient pool as everyone goes through puberty and a high % of people suffer acne during that time.
Probably a rather callous point of view from the patients perspective but from a Revenue perspective ...........
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-8469
-
- There are more pages in this discussion • 1,781 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
40.5¢ |
Change
-0.010(2.41%) |
Mkt cap ! $737.5M |
Open | High | Low | Value | Volume |
40.0¢ | 41.0¢ | 40.0¢ | $1.614M | 3.976M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 297740 | 40.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.0¢ | 339987 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 72564 | 0.405 |
23 | 969470 | 0.400 |
12 | 785123 | 0.395 |
13 | 945274 | 0.390 |
9 | 681573 | 0.385 |
Price($) | Vol. | No. |
---|---|---|
0.410 | 350112 | 11 |
0.415 | 117372 | 6 |
0.420 | 262531 | 11 |
0.425 | 122269 | 4 |
0.430 | 259082 | 15 |
Last trade - 12.21pm 04/09/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |